3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 37.05
+0.10 (0.27%)
Aug 19, 2026, 1:58 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.84 billion as of August 19, 2026. Its market cap has decreased by -8.64% in one year.
Market Cap
2.84B
Enterprise Value
2.39B
Revenue
159.19M
Ranking
n/a
PE Ratio
205.56
Stock Price
37.05
ChartMarket Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 2.84B, an increase of 3.95%. That is a compound annual growth rate of 0.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 3.09B | -17.79% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.32B |
| Sagittarius Life Science | 3.31B |
| BioGend Therapeutics | 3.14B |
| Shine-On BioMedical | 3.13B |
| Apex Biotechnology | 3.08B |
| Great Novel Therapeutics Biotech & Medicals | 3.06B |
| Intech Biopharm | 2.85B |
| BRIM Biotechnology | 2.70B |